Tag: personalized medicine
-
AVATAR: NASA’s Organ-on-a-Chip for Space Health Futures
NASA’s Bold Step: Putting Astronaut Tissue on Chip As NASA prepares for the Artemis II mission, the agency is not only planning to circle the Moon but also to push the boundaries of space biology. A centerpiece of this effort is the AVATAR project—an acronym for A Virtual Astronaut Tissue Analog Response. The experiment takes…
-
NASA’s AVATAR Chips: Pioneering Space Health by Testing Astronaut Tissues in Orbit
NASA’s AVATAR Chips: A Bold Step in Space Health As NASA prepares for the Artemis II mission, researchers are not only aiming to reach the Moon but to understand the human body’s response to deep-space travel. A key experiment in this effort is AVATAR — A Virtual Astronaut Tissue Analog Response — which places astronaut-derived…
-
We told you we weren’t hysterical. Now the science is in
New evidence reshapes the understanding of depression A landmark international study published in Nature Communications is prompting a rethink on how depressive disorders are understood and treated. Led by researchers at QMIR Berghofer Medical Research Institute in Queensland, the work analyzed the DNA of about 200,000 individuals diagnosed with major depressive disorder across Australia, Europe,…
-
Women and Depression: Groundbreaking Genetic Evidence Calls for Sex-Specific Care
New genetic evidence shifts the conversation on depression In a landmark study published in Nature Communications, researchers from QMIR Berghofer Medical Research Institute in Queensland, Australia, reveal compelling evidence that females carry a higher genetic risk for major depressive disorder than males. The findings come from the analysis of DNA from about 200,000 people diagnosed…
-
New Genetic Findings Highlight Sex Differences in Depression Risk
Groundbreaking Find: Women Show Higher Genetic Risk for Major Depression A landmark study conducted by QMIR Berghofer Medical Research Institute and published in Nature Communications has revealed a striking genetic distinction: females carry a significantly higher genetic risk for major depressive disorder than males. The Australian-led research analyzed the DNA of roughly 200,000 people diagnosed…
-
Ireland launches Phase 2 of national Precision Oncology program to accelerate personalized cancer care
Ireland marks a new chapter in personalized cancer care with Phase 2 of Precision Oncology Ireland On 8 October, Ireland strengthened its commitment to precision medicine with the launch of Phase 2 of Precision Oncology Ireland (POI), the country’s leading and largest cancer research program. The initiative, announced by James Lawless TD, Minister for Further…
-
Advancing Gene Editing: The Role of Lipid Nanoparticles in CRISPR Delivery
Introduction: Why delivery platforms matter in CRISPR medicine CRISPR-based therapies hold immense promise for treating a wide range of diseases, but their success hinges not only on the gene-editing tool itself but also on how the therapeutic payload reaches target cells. With nucleic acid–based CRISPR medicines, delivery is as crucial as the editing technology. While…
-
One Gene, One Disease? The Case for Embracing Genetic Complexity in Medicine
Rethinking Genetic Changing Notions of One Gene, One Disease Genetic inheritance is often taught as a simple equation: a single gene causes a specific trait or illness. In practice, the genome operates as a sprawling network where thousands of variants interact to shape health outcomes. New research pushes us beyond a one-gene-one-disease mindset, arguing that…
-
Ireland’s Cancer Care: From One-Size-Fits-All to Personalised Treatments
From shock to progress: a new era in Irish cancer care When Lydia Whelan discovered an indentation on her breast in the summer of 2024, she faced more than a diagnosis. The 32-year-old learned she had stage 2 breast cancer, a moment that could have derailed many lives. Instead, it underscored a broader shift in…
-
IU Research Combines Sound Waves And AI To Power Faster Biomedical Research
Introduction Researchers at Indiana University’s Luddy School of Informatics, Computing and Engineering are pushing the boundaries of biomedical research by marrying acoustofluidics with artificial intelligence. Acoustofluidics—the manipulation of cells and other biological materials in liquid using sound waves—has long promised a label-free, contactless way to handle delicate biological materials. By integrating AI into this platform,…